Friday, September 28, 2018

Pharmeasy to make acquisitions post $50 million funding

Pharmeasy has been valued at $150 million post the round, as per sources. Existing investors BVP also participated in this round. https://ift.tt/2NGWtbM https://ift.tt/eA8V8J

No comments:

Post a Comment

A profile of Anduril CEO Brian Schimpf, a Palantir alum and self-identified Democrat, as Anduril's defense tech shakes up the US military-industrial complex (Allie Garfinkle/Fortune)

Allie Garfinkle / Fortune : A profile of Anduril CEO Brian Schimpf, a Palantir alum and self-identified Democrat, as Anduril's defens...